Once-daily udenafil 50mg compared with udenafil 200mg on-demand in diabetic men with erectile dysfunction

Trial Profile

Once-daily udenafil 50mg compared with udenafil 200mg on-demand in diabetic men with erectile dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Udenafil (Primary)
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Sponsors Dong-A Pharmaceutical
  • Most Recent Events

    • 05 Oct 2012 Identifier DA8159-DDM-IV added and Dong A Pharmaceutical added as study supporter.
    • 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
    • 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top